June - July2014

CE Schedule Inside

The newsletter of Smith Drug Company

A Division of j M Smith CorporationSpartanburg, SCParagould, AR Valdosta, GA

First in Service. First in Commitment.

SUPER STAR SATURDAY NIGHT FUNJoin us for Hollywood VIP party here at The Westin Savannah Harbor on Saturday night from 630-11pm. Saturday is Hollywood VIP, come dressed in your best nightwear, create your own celebrity character with all the privileges that fame brings!

630-7PDinner and get to know each other7-8:30PSmores around the camp fire with great Savannah Stories and music8:30P Dive In Movie poolside with popcorn and candy

AFTER THE MOVIE:Crafts for all ages from pottery painting, Perla Bead crafts, frame decorating, Candy Art, Stuff a Buddy and much more.

Children’s Program

2014 CE Gift & Trade Show Is Almost Here!

The Westin Savannah Harbor 1 Resort Drive, Savannah, GA 31421

R

July 25th - July 27th

The newsletter of Smith Drug Company A Division of J M Smith Corporation

Spartanburg, SC - Paragould, AR - Valdosta, GA

9098 Fairforest RoadSpartanburg, SC 29301

(800) 572-1216

1104 Jones Road Paragould, AR 72450

(866) 346-9147

1500 Commerce DriveValdosta, GA 31601

(800) 572-1216

• HealthWise™ Circular Program

• DollarWise™ Program

• Good Sense® Controlled Label Program

• Greeting Cards Program

• Continuing Education

• Gift and Trade Show

• Rx QuikShip™

• GeneRx QuikShip™

• Third Party Station

• Pharmacy First

• DrugSmith™ Monthly Newsletter

• Smith Weekly e-Blast

• Diabeticare™ Program

(Medicare Vendor Contracts)

• Hamacher Retail Zone Pricing

• Home Health Care Catalog

• HealthWise Signage Program

• Smith Gift Box Gift Category

• Vials and Vitamin Program

• Direct Mail Advertising

• Well Staffed Customer Service

• Excellent Service Levels

• Store Fixture Program

• Merchandising Services

JUNE/JULY

In this issue

Trade Show Info 2

APhA Opposes DEA Proposal to Reschedule Hydrocodone

4

Most Obamacare exchange enrollees were previously uninsured, survey finds.

5

Ferry Schedule 6-10

Trade Show

Now Available12-15

Levemir Flex-Touch 16

APhA Opposes DEA Proposal to Reschedule HydrocodoneDEA publishes proposed rule; Association signs joint comment letters to agencyOpposing DEA’s proposal to reschedule hydrocodone combination products from Schedule III to Schedule II, APhA’s government affairs team led the development and submission of a joint pharmacy stakeholder comment letter to the agency.

The joint pharmacy comments acknowledge the seriousness of prescription drug abuse but emphasizes that rescheduling may not have an effect on decreasing abuse and would have a negative impact on legitimate patient access to these effective pain medications.

The letter was signed by the American Association of Colleges of Pharmacy, American College of Clinical Phar-macy, Academy of Managed Care Pharmacy, APhA, American Society of Consultant Pharmacists, National Alliance of State Pharmacy Associations, National Association of Chain Drug Stores, and National Community Pharmacists Association.

“It is important to remember that the vast majority of patients taking hydrocodone do so legitimately,” wrote the pharmacy associations. They highlighted that stricter requirements for Schedule II drugs related to prescribing and dispensing would restrict patient access and delay relief of pain, and that rescheduling hydrocodone com-bination products would introduce inefficiencies into the health care system and increase costs “at a time when policy makers are seeking ways to streamline processes and reduce costs.”

DEA has begun the formal rulemaking process following a reclassification recommendation from the U.S. Department of Health & Human Services (HHS). The rescheduling of hydrocodone combination products was initiated by a petition from a physician in 1999, according to a DEA news release. In January 2013, an FDA advi-sory committee voted in favor of reclassification. In December 2013, HHS sent that recommendation to DEA.

On February 27, DEA published in the Federal Register a proposed rule concluding that such medications “have a high potential for abuse, and abuse may lead to severe psychological or physical dependence.” Comments were due April 27.

Now DEA is evaluating the feedback from stakeholders.

Also in response to the proposed rule, the Association signed the National Association of Chain Drug Stores’ joint letter that was cosigned by a number of pain-related advocacy groups outside of pharmacy.

About six in 10 people who bought their own health insurance through Affordable Care Act exchanges were previously uninsured, according to a new survey providing one of the first comprehensive looks at the insurance landscape after the health care law's first open enrollment period.

And although a large majority of people who purchased exchange coverage received financial help from the federal government to pay their premiums, affordability remains a major concern for people buying their own coverage, according to the Kaiser Family Foundation survey.

The findings are an early view into the impact of Obamacare’s coverage expansion on the individual health insurance market after taking effect in January. The Obama administration hasn’t reported how many of the 8 million people selecting health insurance through the exchanges were previously uninsured, and almost every state running its own insurance marketplace is still studying this question. Other surveys have shown that the uninsured rate has fallen in the past few months, though the exchanges’ role in driving down that rate has been unclear.

The Kaiser findings contradict other surveys that found most people who bought exchange coverage already had insurance. A Rand Corp. survey in April found that one-third of exchange enrollees were previously uninsured. McKinsey & Co. last month reported 26 percent of people purchasing plans in the individual market, on and off the exchange, were previously uninsured.

Kaiser senior vice president Larry Levitt said other surveys underestimated the previously uninsured population by asking people about their insurance status over the past year, which doesn’t account for how often people shift in and out of the individual insurance market. For example, a person who was uninsured when purchasing an exchange health plan may have reported previous coverage if he or she had insurance at some other point during the year.http://www.washingtonpost.com

Most Obamacare exchange enrollees were previously uninsured, survey finds.

AGENDA

Smith Drug Company Invites Pharmacists & Technicians to Attend this Continuing Education Program

July 25, July 26 & July 27, 2014The Westin Savannah Harbor Golf Resort Spa

1 Resort Drive, Savannah, GA 31421 (912) 201-2000

Friday – 7/25/20148:00 am-9:30 am: Mobile Technology for Pharmacy Operations and Patient Care: How Connected Do You Want to Be? Presenter: Bill G. Felkey Professor Emeritus Auburn University’s Harrison School of PharmacyLearning Objectives- Pharmacists: 1. List at least three components of a mobile solution strategy for a community pharmacy practice.2. Evaluate efficient and effective applications that can address pharmacy operations and communication internally as well as patient care scenarios externally.3. Identify at least one technology and/or app for immediate adoption and integration into the community pharmacy practice.4. Accurately describe the practice opportunity to communicate with installed users of portable technology within the existing patient population of their pharmacy.Learning Objectives- Technicians: 1. List at least three components of a mobile solution strategy for a community pharmacy practice.2. Evaluate efficient and effective applications that can address pharmacy operations and communication internally as well as patient care scenarios externally.3. Identify at least one technology and/or app for immediate adoption and integration into the community pharmacy practice.

ACPE UAN: 0280-0000-14-054-L04-P & 0280-0000-14-054-L04-T Credits: 1.5 Contact Hours (0.15 CEUs) Knowledge Based

_________________________________________________________________________________________________________________

9:30 am -11:00 am: Injecting Immunization Updates into Community Practice Presenter: Deanna W. McEwen, PharmD, BCPS Director of Introductory Pharmacy Practice Experiences Public Service Assistant University of Georgia College of Pharmacy Ashley N. Hannings, PharmD Public Service Assistant, Division of Experience Programs University of Georgia College of Pharmacy Learning Objective – Pharmacists1. Using a case based approach, evaluate patients for pertinent immunization needs.2. Identify recommendation updates found in the ACIP immunization schedule.3. Identify resources for implementing travel vaccine administration.4. Explore opportunities for expanding immunization practices.Learning Objectives – Technicians 1. Discuss important areas with regards to the need for patient immunization. 2. Recognize the recommendation updates found in the ACIP immunization schedule.3. Identify resources for implementing travel vaccine administration.4. Discuss opportunities for expanding immunization practices.

ACPE UAN: 0280-0000-14-055-L01-P & 0280-0000-14-055-L01-T Credits: 1.5 Contact Hours (0.15 CEUs) Knowledge Based

Friday – 7/25/201411:00 am-12:30 pm: Prevention of Stroke in Nonvalvular Atrial FibrillationPresenter: Mindi S. Miller, PharmD, BCPS Clinical Associate Professor, Department of Clinical and Administrative Pharmacy University of Georgia College of Pharmacy, Athens, Georgia Clinical Pharmacist, Emory Healthcare, Atlanta, Georgia Learning Objectives-Pharmacists:1. Discuss the etiology of atrial fibrillation (AF) and identify patients who are at increased risk for stroke. 2. Differentiate target specific anticoagulants based on pharmacodynamics, safety, and efficacy.3. Discuss strategies to incorporate clinical guidelines into patient care to optimize outcomes while avoiding pitfalls of anticoagulation therapy. 4. Identify appropriate anticoagulant therapy for stroke prevention in patients with comorbidities.Learning Objectives-Technicians:1. Discuss the etiology of atrial fibrillation (AF) and risks for stroke. 2. Summarize some benefits of newer target specific anticoagulants.3. Discuss common strategies to optimize outcomes while avoiding pitfalls of anticoagulation therapy. 4. Recognize the need for anticoagulant therapy for stroke prevention in patients with comorbidities.

ACPE UAN: 0280-0000-14-056-L01-P & 0280-0000-14-056-L01-T Credits: 1.5 Contact Hours (0.15 CEUs) Knowledge Based

___________________________________________________________Saturday, 7/26/2014 7:30 am -8:30 am: The Known Unknown: The Often Hidden Role of Pharmacists in Disaster ResponsePresenter: Scott Minarcine, MA Public Health Emergency Preparedness Director Health Protection Division, Georgia Department of Public Health Rejani T. Rajan, PharmD Pharmacy Disaster Response Coordinator Health Protection Division, Georgia Department of Public HealthLearning Objectives-Pharmacists:1. Discuss the role local and retail pharmacists have played in past disaster responses in Georgia.2. Describe the current public health and healthcare community emergency preparedness programs in Georgia.3. Summarize the role that local and retail pharmacists can play in planning, preparing and responding to future disasters.Learning Objectives-Technicians:1. Discuss the role local and retail pharmacists have played in past disaster responses in Georgia.2. Describe the current public health and healthcare community emergency preparedness programs in Georgia.3. Summarize the role local and retail pharmacists can play in planning, preparing and responding to future disasters.

ACPE UAN: 0280-0000-14-057-L04-P & 0280-0000-14-057-L04-T Credits: 1.0 Contact Hours (0.10 CEU) Knowledge Based _________________________________________________________

1:00 pm- 2:00 pm: Drug Nutrient Depletions and Supplements: The Pharmacist’s RolePresenter: James Bennett RPh, FACA, CDE Director of Clinical Services James Bennett Apothecary Corinth, MississippiLearning Objectives-Pharmacists:1. Clarify the latest nutrient recommendations as stated in current literature by organizations such as the American Heart Association, the National Osteoporosis Organization, American Diabetes Association and others.2. Identify common drug nutrient depletion issues and advise on proper supplements including dosing to address those issues.3. Provide educational resources for patients and health care professionals on nutrient depletion and the use of supplements.Learning Objectives-Technicians:1. Clarify the latest nutrient recommendations as stated in current literature by organizations such as the American Heart Association, the National Osteoporosis Organization, American Diabetes Association and others.2. Discuss common drug nutrient depletion issues and proper supplements to address the issues.3. Provide educational resources on nutrient depletion and the use of supplements.

ACPE UAN: 0280-0000-14-058-L01-P & 0280-0000-14-058-L01-T Credits: 1.0 Contact Hour (0.10 CEU) Knowledge Based

Saturday, 7/26/2014 2:00 pm-3:30 pm: Star Ratings: What You Need to KnowPresenter: David D. Pope, PharmD, CDE Chief of Innovation, Co-Founder Creative Pharmacist BrandsLearning Objectives-Pharmacists: 1. Describe the background of Star Ratings in the Medicare space.2. Describe the future impact of star ratings on the pharmacy landscape.3. Detail the EQuIPP platform and star ratings measures.4. List simple ways to improve star ratings within the pharmacy.Learning Objectives – Technicians1. Describe the background of Star Ratings in the Medicare space.2. Describe the future impact of star ratings on the pharmacy landscape.3. Detail the EQuIPP platform and star ratings measures.4. List simple ways to improve star ratings within the pharmacy.

ACPE UAN: 0280-9999-14-059-L03-P & 0280-9999-14-059-L03-T Credits: 1.5 Contact Hours (0.15 CEUs) Knowledge Based___________________________________________________________

3:30 pm -5:30 pm: Diabetes Self-Management: A Focus on Injectables and Injection TechniquePresenter: Jennifer Goldman-Levine, PharmD, CDE, BC-ADM, FCCP Professor of Pharmacy Practice, MCPHS University Clinical Pharmacist, Well Life Medical, Salem, MA Learning Objectives-Pharmacists: 1. Given patient-specific information, apply the American Diabetes Association and American Association of Clinical Endocrinologists’ recommendations for patient specific injectable drug therapy recommendations.2. Recommend strategies to minimize clinician and patient barriers to the use of injectable products.3. Demonstrate the appropriate technique for injecting insulin, using insulin pens, GLP1 agents, and insulin pen needles for patients with type 2 diabetes.4. Describe available needle options and evidence-based injection techniques including pen and syringe needle length and selection, injection site selection, absorption and glucose variability.Learning Objectives-Technicians: 1. Discuss the American Diabetes Association and American Association of Clinical Endocrinologists’ recommendations for patient specific injectable drug therapy recommendations.2. Recognize strategies to minimize patient barriers to the use of injectable products.3. Recognize the appropriate technique for using injection devices for insulin and GLP1 agents for patients with type 2 diabetes.4. Describe needle options and evidence-based injection techniques.

ACPE UAN: 0280-0000-14-060-L01-P & 0280-0000-14-060-L01-T Credits: 2.0 Contact Hours (0.20 CEUs) Application BasedThis activity is supported through educational grants from: Novo Nordisk and Lilly

Sunday, 7/27/2014 7:30 am - 8:30 am: ACC/AHA Updated Guidelines for Treatment of High CholesterolPresenter: James Bennett RPh, FACA, CDE Director of Clinical Services James Bennett Apothecary Corinth, MississippiLearning Objectives – Pharmacists1. Compare and contrast the differences in the updated ACC/AHA Guidelines to previous guidelines.2. Summarize the four major groups who may benefit from statin use.3. Identify the appropriate statin group, dosing, potential interactions or adverse effects based on a patient profile.4. Communicate the updated ACC/AHA cholesterol guidelines to patients and prescribers.

Learning Objectives – Technicians1. Discuss the differences in the updated ACC/AHA Guidelines to previous guidelines. 2. Summarize the four major groups who may benefit from statin use.3. Recognize the appropriate statin group and dosing based on a patient profile.

ACPE UAN: 0280-0000-14-061-L01-P & 0280-0000-14-061-L01-T Credits: 1.0 Contact Hour (0.10 CEU) Knowledge-Based________________________________________

8:30 am -10:00 am: Update on HIV Treatment and PreventionPresenter: Saira Rab, PharmD, BCPS (AQ-ID) Infectious Disease Clinical Pharmacist Specialist Grady Health System, Atlanta, GALearning Objectives – Pharmacists1. Review current preferred regimens for initial therapy in treatment naïve, HIV-infected patients, based upon current DHHS Guidelines.2. Explain the role of current preferred and alternative regimens for HIV treatment that have reduced pill burden, including the role of single tablet regimens in medication adherence.3. Discuss the point of care HIV testing methods available to the community pharmacy for public use.4. Review the role of antiretrovirals in pre-exposure prophylaxis (PrEP).5. Summarize the role of the pharmacist as it relates to adherence counseling, identification of drug interactions, and HIV testing. Learning Objectives – Technicians1. Recognize there are preferred regimens for initial therapy in treatment naïve, HIV-infected patients. 2. Discuss the benefits of HIV treatments regimens that have reduced pill burden.3. Summarize the point of care HIV testing methods available to the community pharmacy for public use.4. Review the role of antiretrovirals in pre-exposure prophylaxis (PrEP).5. Discuss the importance of adherence, drug interactions, and HIV testing.

ACPE UAN: 0280-9999-14-062-L02-P & 0280-9999-14-062-L02-T Credits: 1.5 Contact Hours (0.15 CEUs) Knowledge-BasedThis activity is supported through an educational grant from: Southeast AIDS Training and Education Center ________________________________________10:00 am -11:00 am: DEA Regulatory Update for Pharmacists on Dispensing Controlled Substances (Law)Presenter: David M. Hargroder Diversion Group Supervisor, DEA –Savannah Residence Office Learning Objectives – Pharmacists1. Discuss the current trends with regards to the diversion and abuse of controlled substances. 2. Explain common DEA record-keeping violations cited during inspections related to areas such as inventory, 222 forms, CSOS and reporting theft or losses.3. Identify the responsibilities of the pharmacist when dispensing a prescription for controlled substances. Learning Objectives – Technicians1. Discuss the current trends with regards to the diversion and abuse of controlled substances. 2. Explain common DEA record-keeping violations cited during inspections related to areas such as inventory, 222 forms, CSOS and reporting theft or losses.3. Identify the responsibilities when dispensing a prescription for controlled substances.

ACPE UAN: 0280-0000-14-063-L03-P & 0280-0000-14-063-L03-T Knowledge-Based Credits: 1.0 Contact Hours (0.10 CEU)

Sunday, 7/27/2014 ________________________________________11:00 am -12:30 pm: Evaluating the Changing Landscape in the Management of Hepatitis C InfectionPresenter: Kristi Quairoli, PharmD, BCACP Ambulatory Care Clinical Pharmacist Grady Health System, Atlanta, GALearning Objectives- Pharmacists:1. Identify patients who should be screened for HCV infection and encourage point of care testing.2. List current recommendations for managing HCV based upon consensus guidelines from AASLD and IDSA.3. Discuss common side effects associated with direct acting antivirals, pegylated interferon, and ribavirin and how to manage them.4. Review the role of new and future medications likely to be approved by the FDA.

Learning Objectives- Technicians:1. Recognize who should be screened for HCV infection.2. Discuss current recommendations for managing HCV.3. Recognize common side effects associated with direct acting antivirals, pegylated interferon, and ribavirin.

ACPE UAN: 0280-9999-14-064-L01-P & 0280-9999-14-064-L01-T Knowledge-Based Credits: 1.5 Contact Hour (0.15 CEUs)This activity is supported through an educational grant from: Southeast AIDS Training and Education Center ________________________________________

Target Audience:• Accredited for Pharmacists & Pharmacy Technicians

Participant Requirement for Credit:• To receive credit, participants must fully attend each session as well as pass in a completed signature verification form with NAPB e-profile number and birth date information (No partial credit will be given). • Participants can earn Continuing Pharmacy Education credits for this program by electronically logging onto the website https://ce.ahrevents.com/ and completing the session evaluation form for session(s) attended within 60 days of session date. After completion of the activity evaluation, your continuing pharmacy education credit is automatically reported to CPE Monitor where a certificate of credit can be printed. Please allow up to 48 hours for credit to be available on the CPE Monitor. • Participant names will be checked against program attendance sheets for verification of attendance.*Only Certificates of Credit issued from CPE Monitor are valid in the US* * CPE Monitor will not accept credits after 60 days from the session date*

Disclosure & Evaluation: Disclosure will be made on the day of the program regarding any interest or affiliation a speaker may have with a supporting organization. All participants will have the opportunity to evaluate the educational session and presenter as well as the ability to identify their future educational needs.Accreditation Statement: American Health Resource is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Departures from :City HallLanding

Hyatt

Trade CenterLandingWestin

Waving GirlLandingMarriott

7:00 AM 7:10 AM *7:20 AM 7:30 AM *7:40 AM 7:50 AM *8:00 AM 8:10 AM 8:20 AM8:30 AM 8:40 AM 8:50 AM9:00 AM 9:10 AM 9:20 AM9:30 AM 9:40 AM 9:50 AM

10:00 AM 10:10 AM 10:20 AM10:30 AM 10:40 AM *11:00 AM 11:10 AM 11:20 AM11:30 AM 11:40 AM 11:50 AM12:00 PM 12:10 PM 12:20 PM12:30 PM 12:40 PM 12:50 PM1:00 PM 1:10 PM 1:20 PM1:30 PM 1:40 PM 1:50 PM2:00 PM 2:10 PM 2:20 PM2:30 PM 2:40 PM 2:50 PM3:00 PM 3:10 PM 3:20 PM3:30 PM 3:40 PM 3:50 PM4:00 PM 4:10 PM 4:20 PM4:30 PM 4:40 PM 4:50 PM5:00 PM 5:10 PM 5:20 PM5:30 PM 5:40 PM 5:50 PM6:00 PM 6:10 PM 6:20 PM

* * *6:40 PM 6:50 PM *7:00 PM 7:10 PM *7:20 PM 7:30 PM *7:40 PM 7:50 PM *8:00 PM 8:10 PM *8:20 PM 8:30 PM *8:40 PM 8:50 PM *9:00 PM 9:10 PM *9:20 PM 9:30 PM *9:40 PM 9:50 PM *

10:00 PM 10:10 PM *10:20 PM 10:30 PM *10:40 PM 10:50 PM *11:00 PM 11:10 PM *11:20 PM 11:30 PM *11:40 PM 11:50 PM *12:00 AM * *

Ferry Schedule

Getting to and from the Savannah Westin

Savannah Belles Ferry operates daily, year round, except Thanksgiving, Christmas and New Year’s days.

Service Locations

Trade Center Landing - betweenTrade Center and Westin Hotel

City Hall Landing - River Walk At City Hall,adjacent to Hyatt Hotel.

Waving Girl Landing - River Walk,adjacent to Marriott Hotel

Service Schedules

The Savannah River is a busy commercial waterway, with special US Coast Guard regulations for vessels. The Ferry

may sometimes be delayed briefly by visibility or large vessel traffic in the area.

We appreciate your patience.

Savannah Belle Ferry System is operated by Chatham Area Transit (CAT). For information,

www.catchacat.org, or (912) 447-4029.

Thanks for riding with us!

Travel Size Bottles Just in time for Summer!

Item number Description585752 TRV SZ CREST WHTN/SCOPE O/LAST585760 TRV SZ DAISY CLASS DISP 2PK364174 TRV SZ GILL FOAMY SHV CR REG585778 TRV SZ GOOD NEWS DISP 2CT357525 TRV SZ HEAD N SHL SHAM CL CLN585786 TRV SZ HERB ESS SH HELLO HYDR585794 TRV SZ HERB ESS COND HELLO HYD585802 TRV SZ OLAY BODY WASH 50ML585810 TRV SZ OLAY MOIST LOTION585828 TRV SZ OLD SPICE RZ IS SWAGGER585836 TRV SZ OLD SPICE BW RZ SW585844 TRV SZ ORAL B TB INDICAT 40 MD585851 TRV SZ FEBREZE AIR EFFECT XS585885 TRV SZ TIDE TO GO MINI213876 TRV SZ ORAL B FLOSS WAX MINT505297 TRV SZ PANTEN SHAMP FINE 1.7Z505305 TRV SZ PANTENE COND FINE 1.7OZ505388 TRV SZ PANTENE HS N/AERO FINE585893 TRV SZ TO GO CHERRY CHEW(VIAL)585901 TRV SZ SATIN CARE SH GEL SENS585919 TRV SZ SCOPE ORIG MINT 44ML361766 TRV SZ SECRET INV SLD POW FRS332387 TRV SZ TAMPAX REGULAR ORIGINL326470 TRV SZ TIDE 2XULTR MACH 1-LOAD441006 TRV SZ OLAY DAILY FACIALS 3CT

The key to a successful travel station is to keep it fully stocked!

Zanfel® Poison Ivy, Oak & Sumac Wash is a safe and effective topical solution for poison ivy, poison oak, and poison sumac. It is the only product known to remove urushiol, the toxin responsible for the reaction, from the skin after bonding, enabling the affected area to immediately begin healing. After using Zanfel®, the itching and pain are the first things to be relieved, usually within 30 seconds.

Smith Number - 119651

Every summer, millions of Americans dig their swimsuits out of the back of their closets and flock to their favorite beaches. And whether their goals are to beef up their backstrokes, get lost in books or show off their beach-ready bodies, they all have to worry about ultraviolet rays from the sun.

Too much sun today equals sensitive, red skin and lots of peeling tomorrow. But it also affects your skin's future health -- intense exposure to ultraviolet rays can increase your chances of getting premature wrinkles, liver spots and even skin cancer, including melanoma [source: Mayo Clinic].

But there's no need to spend the summer months hiding in a cold, dark basement. Plenty of products and techniques can help you enjoy the outdoors while staying safe from harmful sunburns. A popular first line of defense is a big bottle of sunscreen, but that isn't foolproof: Sunscreens must be frequently reapplied when we perspire, and even waterproof brands wear off after a few hours [source: Centers for Disease Control and Prevention].

In addition to the many sunscreen lotions and sprays that drug stores carry, there are now some alternative ways of protecting yourself from the damaging effects of the sun. Certain brands of clothing also claim to help protect the skin from harmful ultraviolet (UV) rays, and specific foods have emerged as aids in sunburn prevention.http://health.howstuffworks.com/

How to Prevent Sunburn

066373

713438

612325

134650

Patented, penetrating, pain-relief lotion. Dr. and Pharmacist recommended for over 15 years. Penetran-Plus interferes with pain signals and helps reduce swelling. With unique ingredients not found in any other pain relief product, PenetranPlus does not mask pain with hot or cold sensations. Clinically studied for relief of pain from arthritis, bursitis, ten-donitis, also effective on insect bites and stings, sunburn, bruises, shin splints, neuropathy, sports injuries, and many other aches and pains. Plus Natural Lemon Oil provides a mild, refreshing scent.

562512 PENETRAN PLUS PAIN LOT 2.5Z

PENETRAN PLUS PAIN LOTION

A natural solution to moisturize nasal passages

- 100% pure sesame oil USP grade- Rich in antioxidant Vitamin E- Free of allergy causing proteins

Lubricates and moisturizes nasal mucosa- Provides comfort for nasal passages- Gives freedom from itchy

and burning sensations- Decreases formation of nasal crust

Clinically proven natural comfort for dry nasal passages - Unique Swedish formula

Store at room temperature not to exceed 77°F, and protect from light.

NASAL SPRAY®

Coming Soon

Nozoil

A revolutionary preservative-free ophthalmic emul-sion that moisturizes lubricates and protects moderate to severe dry eyes.

671404 RETAINE HPMC .3% 10ML 672253 RETAINE MGD OPTH EMULSION

Coming Soon!

Watch for Discounts Coming in July!

Get in touch with your Novo Nordisk representative or visit levemirpro.com today

a Intended as a guide. Lower acquisition costs alone do not necessarily refl ect a cost advantage in the outcome of the condition treated because there are other variables that affect relative costs. Formulary status is current as of March 2014 and is subject to change.

b By texting FLEX to 51212, you consent to receive a one-time text message containing a link to the requested information from Novo Nordisk. Your consent is voluntary and you are not required to consent to receive information or other benefi ts from Novo Nordisk. Standard text messaging rates will apply.

We designed FlexTouch®Because we can’t redesign thumbs

The only prefi lled insulin pen with no push-button extension

• Available from 1 to 80 units

• Available on more than 96% of managed care plans nationwide1,a

Introducing NEW Levemir® FlexTouch®

Text to Experience FlexTouch®

Text FLEX to 51212 to learn more about Levemir ® FlexTouch®b

FlexTouch® and Levemir ® are registered trademarks of Novo Nordisk A/S. © 2014 Novo Nordisk Printed in the U.S.A. 0314-00020589-1 June 2014

Needles are sold separately and may require a prescription in some states.

Reference: 1. Fingertip Formulary®, March 2014.